#SBTi #Greenhouse Gases #WuXi AppTec

WuXi AppTec's Milestone in Sustainability

On June 17, 2025, WuXi AppTec, a prominent global provider of R&D and manufacturing services for the pharmaceutical and life sciences sectors, proudly announced that its near-term greenhouse gas (GHG) emissions reduction targets have been validated by the Science Based Targets initiative (SBTi). This significant achievement reflects WuXi AppTec's unwavering commitment to sustainability and responsible corporate practices.

The SBTi’s validation confirms that WuXi AppTec's targets align with the imperative to limit global temperature rise to 1.5°C — a critical goal in the fight against climate change. Among the ambitious goals set, the company aims to cut its absolute Scope 1 and Scope 2 GHG emissions by 42% by 2030, using 2024 levels as a baseline. Additionally, WuXi AppTec plans to reduce Scope 3 GHG emissions associated with its purchased goods and services, along with fuel and energy-related activities, by a notable 25% within the same period.

Dr. Steve Yang, Co-CEO and Chairman of WuXi AppTec's ESG Committee, expressed pride in this validation, stating, “This recognition underscores our commitment to corporate social responsibility, scientific rigor, and transparency related to our greenhouse gas emission reduction efforts. We are devoted to supporting our customers in delivering innovative therapies worldwide while progressing toward a healthier, more sustainable future.”

To achieve these critical targets, WuXi AppTec is embarking on an array of initiatives aimed at enhancing energy efficiency and minimizing carbon emissions. Key strategies include process optimization, upgrading equipment, renovating infrastructure, and integrating technological innovations. The company is also focusing on increasing renewable energy usage by investing in green electricity and photovoltaic power generation facilities.

Moreover, WuXi AppTec recognizes the importance of collaboration in its sustainability journey, engaging with suppliers to significantly reduce GHG emissions linked to purchased goods and services. This partnership approach plays a vital role in fostering a low-carbon supply chain that aligns with WuXi AppTec’s sustainability priorities.

WuXi AppTec's dedication to sustainability has been recognized through various accolades, including an AA rating in the MSCI ESG ratings for four consecutive years and inclusion in the Dow Jones Sustainability Index (DJSI) for the same duration. The firm also boasts an A- Leadership rating in the CDP Climate Change rating for three years in a row and has been acknowledged as a Top-Rated Company in the Industry and Regional ESG categories by Morningstar Sustainalytics.

To bolster its pledge toward sustainability, WuXi AppTec has joined the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI) as a supplier partner. These affiliations reinforce WuXi AppTec's role as a significant player in global health, demonstrating the importance of corporate responsibility in the pursuit of innovations in life sciences.

As a proactive participant in the global pharmaceutical sector, WuXi AppTec aims to seamlessly integrate sustainability into every facet of its operations. Through open-access platforms and end-to-end service offerings, the company is making strides in improving global health while working towards the ambitious vision that